Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05028894 · ClinicalTrials.gov registry record
23andMe IPF Research Study
A clinical trial, sponsored by 23andMe.
- Completed
- Registry status
- 690
- Enrollment target
NCT05028894 is a clinical trial that has completed, run by 23andMe. The registered enrollment target is 690 participants.
The verdict
NCT05028894 has completed, sponsored by 23andMe.
- COMPLETED
- Registry status
- 690 participants
- Enrollment target
Study Summary
The long term goal of this study is to increase genetic understanding of IPF to enable the development of an effective drug for IPF that can improve the lives of those living with the condition.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 690 participants |
| Start Date | 2020-06-05 |
| Est. Completion | 2023-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05028894
The ClinicalTrials.gov registry entry for NCT05028894 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 690 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 23andMe, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT05028894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05028894 about?
NCT05028894 is a clinical study titled "23andMe IPF Research Study". The long term goal of this study is to increase genetic understanding of IPF to enable the development of an effective drug for IPF that can improve the lives of those living with the condition.
What is the current status of trial NCT05028894?
This trial is currently completed. The enrollment target is 690 participants. The study started on 2020-06-05. Estimated completion is 2023-05-05.
What interventions are being tested in trial NCT05028894?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05028894?
This trial is sponsored by 23andMe, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.